Abstract:We review here the functional and kinetic characteristics of highly purified hematopoietic CD34+ mobilized into peripheral blood (PB) by granulocyte colony-stimulating factor (G-CSF) with or without chemotherapy for autologous or allogeneic transplantation. Circulating CD34+ cells were evaluated for their colony-forming capacity and trilineage proliferative response to selected recombinant human (rh) CSF in vitro, and the content of very primitive long-term culture initiating cells (LTC-IC). In addition, the cycling status of PB CD34+ cells, including committed clonogenic progenitor cells and the more immature LTC-IC, was determined by the cytosine arabinoside (Ara-C) suicide test and the acridine orange (AO) flow cytometric technique. By comparison, bone marrow (BM) CD34+ cells from the same individuals were studied under steady-state conditions and during G-CSF administration. Clonogenic assays in methylcellulose showed the same frequency of colony-forming unit cells (CFU-C) when PB primed-CD34+ cells and BM cells were stimulated with phytohemagglutinin-lymphocyte-conditioned medium (PHA-LCM). However, mobilized CD34+ cells were significantly more responsive than their steady-state BM counterparts to interleukin-3 (IL-3) and stem cell factor (SCF) combined with G-CSF or IL-3 in the presence of erythropoietin (Epo). Conversely, circulating and BM megakaryocyte precursors (CFU-MK) showed the same clonogenic efficiency in response to IL-3, GM-CSF and IL-3, IL-6 and Epo. Interestingly, very few CD34+ cells expressed the Mpl receptor and this finding resulted in the lower proliferative response of mobilized CFU-MK to the Mpl-ligand (megakaryocyte growth and development factor; MGDF), as compared to BM cells. After 5 weeks of liquid culture supported by the engineered murine stromal cell line M2-10B4 to produce G-CSF and IL-3, we reported a similar frequency of LTC-IC in PB and steady-state BM. Kinetic studies on PB and BM CD34+ cells, including LTC-IC, showed the low number of circulating progenitor cells in S and G2M phase whereas simultaneous DNA/RNA analysis and the Ara-C suicide assay demonstrated that the majority of PB CD34+ cells and LTC-IC are not quiescent (ie in G0 phase) being in G1 phase. Moreover, G-CSF administration prevented apoptosis in a small but significant proportion of mobilized CD34+ cells. Thus, our results indicate that mobilized and BM CD34+ cells can be considered equivalent for the frequency of both committed and more immature hematopoietic progenitor cells, although they show different kinetic and functional profiles. A further set of experiments indicated that G-CSF treatment did not alter the alloantigen presenting function of CD34+ cells which was mainly mediated by the upregulation of costimulatory molecules upon coincubation with allogeneic T cells. Taken together, these findings should allow a better understanding of PBSC transplantation.

Experimental Study on Hematopoietic Reconstruction Effects of Peripheral Blood Stem Cells Mobilized by Anti-Cd49d Monoclonal Antibody Plus Rhg-Csf in Mice

A Retrospective Study of Autologous Stem Cell Mobilization by G-CSF in Combination with Chemotherapy in Patients with Multiple Myeloma and Lymphoma.

[Study of Ex Vivo Expansion of Mouse Hematopoietic Stem/progenitor Cells and the Use of Them for Hematopoiesis Reconstitution].

Effects of Expanded Hematopoietic Stem/progenitor Cells on Mouse Hematopoietic Recovery:Rapid Hematopoietic Recovery, Long-Term Engraftment and Endogenous Recovery

Experimental Study on Ex Vivo Expanded Hematopoietic Stem/progenitor in the Two Step Culture from Human Umbilical Cord Blood Transplanted into NOD/SCID Mice

Ex Vivo Expansions and Transplantations of Mouse Bone Marrow-Derived Hematopoietic Stem/progenitor Cells

[Study on Hematopoiesis Reconstitution by Co-Transplant of Human Bone Marrow Mesenchymal Stem Cells and Umbilical Cord Blood CD34(+) Cells at Different Ratios in NOD/SCID Mice].

Ex Vivo Expansion and Transplantation of Hematopoietic Stem/progenitor Cells Supported by Mesenchymal Stem Cells from Human Umbilical Cord Blood.

Clinical Study of G-CSF Mobilized Allogeneic Bone Marrow Cells Plus Peripheral Blood Stem Cells Transplantation for Hematological Diseases

Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis

The Effect of Rhg-CSF on MDSC in Bone Marrow and Peripheral Blood Cells

[Hematopoietic Reconstitution by Co-Transplantation of Human BM-MSCs and UCB CD34+ Cells at Various Times in NOD/SCID Mice].

Macrophages Ameliorate Bone Marrow Inflammatory Injury and Promote Hematopoiesis in Mice Following Hematopoietic Stem Cell Transplantation.

Experimental Study on Reparative Effect of Human Umbilical Cord Blood Stromal Cells Transplantation on Hematopoietic Damage

Establishment of a Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation Model in Mice and Its Related Study

[Mobilization of Autologous Peripheral Blood Stem Cells by Chemotherapy and Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)].

Role of Adhesion Molecules in Mobilization of Hematopoietic Cells

Biological characterization of CD34+ cells mobilized into peripheral blood

Experimental Study on the Effects of Granulocyte Colony-stimulating Factor and Stem Cell Factor on Proliferation and Mobilization of Bone Marrow Mononuclear Cells

NOD/SCID Mice Hematopoietic Repopulating Ability of Ex Vivo Expanded Umbilical Cord Hematopoietic Blood Cells Which Co-cultured with MSCs from Human Umbilical Cord Blood

Cotransplantation of human umbilical cord blood-derived stromal cells and human umbilical cord blood-mononuclear cells accelerates hematopoietic reconstruction and engraftment in radiation-injured mice